IP Verse

Combinations Of Liposomal Irinotecan, 5 Fu And Leucovorin For The Treatment Of Pancreatic Cancer - EP3266456

PATENT ANALYSIS

Patent Details

Grant Date
May 5, 2021
Company
IPSEN BIOPHARM LTD.
Oppositions

GENERICS [UK] LIMITED

SANDOZ AG

TEVA PHARMACEUTICAL INDUSTRIES LTD.

More patents of Ipsen Biopharm Ltd.

EP3266456

EP3337467

EP3337478

Want to monitor this patent?

Feel free to send us a message here and we will get back to you